Search

Jay J Wu

from Fremont, CA
Age ~62
Get Report
Also known as:
Jay Jie Qiang Wu, Jie Qiang Wu, Jie Q Wu, Jie Yang Xia Wu, Jie Q Wuu, Jie Qwu
Phone and address:
34069 Frederick Ln, Fremont, CA 94555
(510) 818-0889
Related to:
Zhao Wu, 64Li H Wang, 47Li L Wanglai, 64Hongwen Zhu, 37Julie Zhu
Connected to:
Agna J Wu, 42Al Y Wu, 87Alena C Wu, 55Alis W Wu, 35Altaira R Wu, 52Amanda B Wu, 42Amy Wu, 51Anastasia M Wu, 46Andi Wu, 35Andria J Wu, 34

Jay Wu Phones & Addresses

  • 34069 Frederick Ln, Fremont, CA 94555 (510) 818-0889 (510) 818-1018 (510) 894-3469
  • 1212 Whipple Ave #416, Redwood City, CA 94062
  • 1111 J St #4, Davis, CA 95616 (530) 753-4951
  • 200 Solano Park Cir #E, Davis, CA 95616 (530) 753-4951
  • San Diego, CA
  • Alameda, CA
  • Mountain View, CA
  • Lancaster, CA

Work

Company: Vm discovery inc Address: 45535 Northport Loop E, Fremont, CA 94538 Phones: (510) 818-1018 Position: Chief executive officer Industries: Pharmaceutical Preparations

Ranks

Licence: New Jersey - Active Date: 1996

Professional Records

License Records

Jay Wu

License #:
47413 - Active
Category:
Professional
Issued Date:
Feb 26, 2008
Expiration Date:
Mar 31, 2020

Lawyers & Attorneys

Jay Wu Photo 1

Jay Hong Wu - Lawyer

View page
Licenses:
New Jersey - Active 1996

Resumes

Resumes

Jay Wu Photo 2

Consultant At Bain & Company

View page
Location:
San Francisco Bay Area
Industry:
Management Consulting
Jay Wu Photo 3

Co-Founder

View page
Location:
San Francisco, CA
Work:

Co-Founder

American High School
Jay Wu Photo 4

Jay Wu

View page
Industry:
Internet
Jay Wu Photo 5

President And Chief Executive Officer

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Thomas J Long School of Pharmacy and Health Science University of the Pacific California
Adjunct Professor, Pharmaceutics and Medicinal Chemistry
Vm Discovery
President and Chief Executive Officer
Skills:
Medicinal Chemistry
Lifesciences
Clinical Trials
Biotechnology
Biochemistry
Drug Discovery
Biopharmaceuticals
Technology Transfer
Clinical Development
Molecular Biology
Cancer
Venture Capital
Drug Development
Protein Chemistry
Commercialization
Life Sciences
Oncology
Jay Wu Photo 6

Jay Wu

View page
Jay Wu Photo 7

Jay Wu

View page
Jay Wu Photo 8

Technical Consultant At Hp

View page
Position:
Technical Consultant at HP
Location:
San Francisco Bay Area
Industry:
Computer Software
Work:
HP
Technical Consultant
Jay Wu Photo 9

Jay Wu

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jay Wu
President
Precisionwerkz Architectural Woodwork & Cabinetry
Precisionwerkz Canada Inc
Cabinets. Kitchen Cabinets & Equipment. Millwork
4155 McConnell Dr, Burnaby, BC V5A 3J7
(604) 422-8920, (604) 422-8921
Mr. Jay Wu
Vice President
Memories of Life, Inc.
Funeral Related Services
1048 Serpentine Ln STE 301, Pleasanton, CA 94566
(888) 998-0570, (925) 600-0264
Jay Wu
Chief Executive Officer
Vm Discovery Inc
Pharmaceutical Preparations
45535 Northport Loop E, Fremont, CA 94538
Jay Wu
President And Chief Executive Officer
Vm Discovery Inc
Pharmaceutical Preparations
45535 Northport Loop E, Fremont, CA 94538
Jay Wu
President
Precisionwerkz Architectural Woodwork & Cabinetry
Cabinets · Kitchen Cabinets & Equipment · Millwork
(604) 422-8920, (604) 422-8921
Jay J. Wu
President
Fremont Sciences, Inc
Business Services at Non-Commercial Site · Nonclassifiable Establishments
34069 Frederick Ln, Fremont, CA 94555
35485 Dumbarton Ct, Newark, CA 94560
Jay J. Wu
President, Chief Executive Officer, President And Chief Executive Officer
VM DISCOVERY, INC
Druggists' Preparations (Pharmaceuticals)
45535 Northport Loop E, Fremont, CA 94538
45800 Northport Loop W, Fremont, CA 94538
(510) 818-1018, (510) 661-6770, (510) 868-4543
Jay Wu
Vm Therapeutics LLC
45535 Northport Loop E, Fremont, CA 94538
Jay Wu
President And Chief Executive Officer
Vm Discovery Inc
Pharmaceutical Preparations
45535 Northport Loop E, Fremont, CA 94538

Publications

Us Patents

Compositions And Methods For Apoptosis Modulators

View page
US Patent:
8618110, Dec 31, 2013
Filed:
Feb 9, 2010
Appl. No.:
12/702651
Inventors:
Jay Jie-Qiang Wu - Fremont CA, US
Ling Wang - Union City CA, US
Assignee:
VM Discovery Inc. - Fremont CA
International Classification:
A61K 31/5377
A61K 31/496
A61K 31/454
A61K 31/422
A61K 31/4192
C07D 487/04
C07D 417/14
C07D 413/14
C07D 413/12
C07D 413/10
C07D 405/14
C07D 401/14
C07D 401/06
C07D 403/14
C07D 403/10
C07D 403/06
US Classification:
51425406, 51425218, 51425219, 51425304, 5142531, 51425311, 51425402, 51425404, 5142328, 514278, 514322, 514375, 514377, 514359, 544121, 544349, 544357, 544364, 544367, 544366, 548217, 548259, 546 16, 546199
Abstract:
The present invention includes and relates generally to compounds of structural Formula (I), or a salt, solvate, or prodrug thereof, which modulate apoptosis in cells. The present invention also provides pharmaceutical compositions containing these compounds, methods of making these compounds, and methods of using these compounds and pharmaceutical compositions for treatment of diseases associated with irregular apoptosis in cells.

Method For Treating Pain Syndrome And Other Disorders

View page
US Patent:
20110053960, Mar 3, 2011
Filed:
Aug 27, 2010
Appl. No.:
12/870327
Inventors:
Jay Jie-Qiang WU - Fremont CA, US
Assignee:
VM DISCOVERY INC. - Fremont CA
International Classification:
A61K 31/519
A61P 29/00
A61P 25/06
A61P 25/08
A61P 35/00
A61P 3/10
A61P 9/10
A61P 31/12
A61P 19/02
A61P 25/30
A61P 25/22
A61P 25/24
A61P 25/28
C12N 5/00
US Classification:
51425941, 435375
Abstract:
The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.

Novel Agents Of Calcium Ion Channel Modulators

View page
US Patent:
20110065703, Mar 17, 2011
Filed:
Mar 12, 2008
Appl. No.:
12/530964
Inventors:
Jay Jie-Qiang Wu - Fremont CA, US
International Classification:
A61K 31/5377
C07D 491/08
C07D 498/08
A61K 31/444
A61K 31/407
A61K 31/496
A61K 31/424
A61K 31/4355
A61K 31/4439
A61P 25/08
A61P 25/16
A61P 25/00
A61P 25/18
A61P 9/12
A61P 9/10
A61P 25/22
A61P 25/28
A61P 35/00
A61P 3/10
C07D 487/04
C07D 401/14
C07D 403/06
C07D 513/04
C07D 215/56
C07D 401/04
C07D 413/14
A61K 31/475
A61K 31/519
A61K 31/517
A61K 31/4745
A61K 31/404
A61K 31/4985
A61K 31/10
US Classification:
5142352, 544142, 546256, 548431, 544357, 548218, 544361, 544126, 5142328, 514333, 514411, 51425211, 514375, 51425303, 514291, 514338, 544251, 544363, 544287, 544255, 546156, 544284, 544128, 514312, 5142601, 5142663, 51425216, 514267, 51425308, 514284, 51425217, 51426622, 514415, 514250, 514712
Abstract:
The present invention includes a group of chemical compounds useful as modulators of calcium ion (Ca) channels, especially for T-type, N-Type and L-type channels. The present invention also includes pharmaceutical compositions comprising these calcium ion channel modulating agents and methods of using these calcium ion channel modulating agents for the treatment diseases and conditions associated with the calcium ion channels.

Compositions Of Protein Receptor Tyrosine Kinase Inhibitors

View page
US Patent:
20110301133, Dec 8, 2011
Filed:
Dec 8, 2009
Appl. No.:
13/133565
Inventors:
Jay Jie-Qiang Wu - Fremont CA, US
Ling Wang - San Ardo Union City CA, US
Assignee:
VM Pharma LLC - Fremont CA
International Classification:
A61K 31/56
C07D 471/04
C07D 417/12
C07D 207/06
C07D 403/12
C07D 401/12
A61K 31/496
A61K 31/4985
A61K 31/5415
A61K 31/40
A61K 31/4025
A61K 31/435
A61K 31/404
A61K 31/515
A61K 31/5513
A61P 35/00
A61P 23/00
A61P 25/08
A61P 25/24
A61P 29/00
A61P 9/10
A61P 9/00
A61P 17/06
A61P 21/02
A61P 25/22
A61P 3/10
A61P 31/12
A61P 19/02
A61P 25/30
A61P 25/32
A61P 35/04
C07D 413/14
US Classification:
514171, 544368, 544344, 544 52, 548567, 540203, 546183, 548467, 51425404, 514250, 5142242, 514428, 51421004, 514299, 514414, 514270, 514221
Abstract:
The present invention relates to novel synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of inhibiting or antagonizing a family of receptor tyrosine kinases, Tropomysosin Related Kinases (Trk), in particular the nerve growth factor (NGF) receptor, TrkA. The invention further concerns the use of such compounds in the treatment and/or prevention of pain, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, or a disease, disorder or injury relating to dysmyelination or demyelination or the disease or disorder associated with abnormal activities of NGF receptor TrkA.

Compositions And Methods For Treating Alcohol Use Disorders, Pain And Other Diseases

View page
US Patent:
20110301149, Dec 8, 2011
Filed:
Oct 12, 2009
Appl. No.:
13/123399
Inventors:
Jay Jie-Qiang Wu - Fremont CA, US
Assignee:
VM DISCOVERY INC. - Fremont CA
International Classification:
A61K 31/55
A61K 31/5415
C07D 265/36
C07D 413/12
A61K 31/538
C07D 279/16
C07D 498/04
C07D 241/44
A61K 31/498
C07D 471/04
A61K 31/4985
C07D 401/12
A61K 31/4709
A61K 31/4375
C07D 513/04
A61K 31/542
C07D 417/14
C07D 413/14
A61K 31/4545
C07D 401/06
A61K 31/454
A61K 31/496
A61K 31/5377
C07D 491/113
A61K 31/438
A61P 29/00
A61P 25/04
A61P 25/00
A61P 25/06
A61P 25/22
A61P 21/00
A61P 25/08
A61P 25/32
A61P 25/20
A61P 3/10
A61P 1/16
A61P 17/02
A61P 9/00
A61P 31/00
A61P 37/02
A61P 35/00
C07D 417/12
US Classification:
51421705, 544 52, 5142242, 540599, 544105, 5142305, 544354, 514249, 544350, 546153, 514312, 546122, 514300, 544 48, 544 73, 540597, 51421704, 546187, 514316, 546209, 514326, 544364, 5142531, 544130, 5142368, 546 19, 514278, 544369, 51425402
Abstract:
The present invention provides compounds which antagonize epsilon protein kinase C (PKCε). These compounds have a structural formula (Ia), (Ic) or (II). The present invention also provides pharmaceutical compositions containing these compounds and methods of treating various diseases, conditions, and/or symptoms by using these compounds.

Novel Crystalline Forms

View page
US Patent:
20180177781, Jun 28, 2018
Filed:
Aug 4, 2017
Appl. No.:
15/669132
Inventors:
- Fremont CA, US
Jay Jie-Qiang Wu - Fremont CA, US
International Classification:
A61K 31/519
C07D 471/04
Abstract:
The present invention relates to novel crystalline polymorphic forms of 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one. The present invention also includes the methods of making crystalline polymorphic forms thereof and the use thereof for preparing a pharmaceutical composition.

Methods For Treating Cancer With Trka Receptor Tyrosine Kinase Antagonists

View page
US Patent:
20180078545, Mar 22, 2018
Filed:
Nov 27, 2017
Appl. No.:
15/822919
Inventors:
- Fremont CA, US
Jay Jie-Qiang Wu - Fremont CA, US
Assignee:
VM Oncology LLC - Fremont CA
International Classification:
A61K 31/495
C07D 403/12
C07D 241/04
A61K 31/496
A61K 31/4545
C07D 401/14
C07D 295/116
C07D 401/04
C07D 257/04
C07D 295/155
A61K 31/635
Abstract:
The present disclosure relates to novel synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same, said compounds being capable of inhibiting or antagonizing TrkA receptor tyrosine kinases. In some aspects, the disclosure provides a compound having a structural formula (I):The disclosure further concerns the use of such compounds in the treatment and/or prevention of certain types of cancers, pain, inflammation, restenosis, atherosclerosis, psoriasis, thrombosis, Alzheimer's, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination.

Method For Treating Pain Syndrome And Other Disorders

View page
US Patent:
20160318930, Nov 3, 2016
Filed:
Jul 14, 2016
Appl. No.:
15/210102
Inventors:
- Fremont CA, US
Jay Jie-Qiang Wu - Fremont CA, US
Assignee:
VM Therapeutics LLC - Fremont CA
International Classification:
C07D 471/04
A61K 9/06
A61K 9/00
Abstract:
The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
Control profile
Jay J Wu from Fremont, CA, age ~62 Get Report